Recent progress on anti-Candida natural products

Area of Science:

• Mycology
• Pharmacology
• Natural Products Chemistry

Background:

• Candida species are life-threatening pathogens causing significant morbidity and mortality, especially in immunocompromised individuals.
• The rise of drug-resistant fungi necessitates the development of novel anti-Candida agents due to decreased efficacy of current treatments.
• Natural products are recognized for their complex structures and diverse mechanisms, offering potential leads for new antifungal therapies.

Purpose of the Study:

• To review the landscape of anti-Candida natural products discovered in the last decade.
• To discuss the research progress on various natural fungistatic agents and their novel mechanisms of action.
• To highlight the potential of natural products in combating drug-resistant fungal infections.

Main Methods:

• Literature review of scientific publications from the past ten years focusing on anti-Candida natural products.
• Analysis of research detailing the mechanisms of action of identified natural antifungal agents.
• Identification and discussion of promising natural compounds and their development status, including those in clinical trials.

Main Results:

• Natural products represent a rich source of novel anti-Candida compounds with diverse mechanisms.
• Recent research has identified unique agents, including cell wall inhibitors like YW3548 and SCY-078, currently in clinical trials.
• Understanding the novel mechanisms of these natural products is crucial for overcoming drug resistance.

Conclusions:

• Natural products hold significant promise for developing new and effective agents against intractable Candida infections.
• Continued exploration of nature's chemical diversity is vital for discovering antifungals that circumvent existing resistance mechanisms.
• The development of novel antifungals from natural sources is critical for improving outcomes in immunocompromised patients facing resistant fungal pathogens.